Physician profile
Ann Q Vu
NPI 1497848295
$2,580.21
in general payments reported to CMS, 2019-2025
21 companies · $595 in 2025
The $595 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $240 · 2021: $178 · 2022: $148 · 2023: $342 · 2024: $238 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.26 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $694.08 | 2019-2025 | |
| Genzyme Corporation | $359.27 | 2019-2025 | |
| Janssen Biotech, INC. | $175.19 | 2019-2020 | |
| Abbvie INC. | $174.93 | 2019-2025 | |
| Almirall LLC | $165.36 | 2019-2025 | Klisyri |
| Mayne Pharma Commercial LLC | $151.82 | 2019-2025 | |
| Epi Health, LLC | $137.12 | 2019-2020 | |
| Leo Pharma INC. | $133.24 | 2021-2025 | Anzupgo, Adbry |
| Biofrontera INC. | $97.46 | 2019-2024 | Rhodoled Xl, Ameluz, Xepi |
| Sun Pharmaceutical Industries INC. | $79.61 | 2019-2020 | |
| Prugen, INC. Pharmaceuticals | $74.62 | 2019-2020 | |
| Lilly USA, LLC | $68.54 | 2019-2025 | Ebglyss, Taltz |
| Pfizer INC. | $68.22 | 2019-2024 | |
| Amgen INC. | $46.50 | 2019-2025 | Otezla |
| Regeneron Healthcare Solutions, INC. | $29.83 | 2025 | Dupixent |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $28.22 | 2025 | Bimzelx |
| Tandem Diabetes Care, INC. | $23.52 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Galderma Laboratories, L.P. | $22.83 | 2019 | |
| Incyte Corporation | $17.25 | 2025 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.23 | 2020 | |
| Tactile Systems Technology INC | $15.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.